Cryoport, INC Form 4 insider transactions

NASDAQ
Director Daniel M. Hancock of Cryoport, Inc. reports acquisition of stock options and restricted stock rights.
NASDAQ
Director Richard J. Berman reports acquisition of common stock and stock options in Cryoport, Inc.
NASDAQ
Richard J. Berman, a director of Cryoport, Inc., sold 8,105 shares of common stock at a weighted average price of $13.4106 on May 15, 2024.
NASDAQ
Edward J. Zecchini, Chief Digital and Tech Officer of Cryoport, Inc., sold 3,443 shares of common stock on May 14, 2024, to cover tax obligations related to vesting restricted stock rights.
NASDAQ
Cryoport's Chief Financial Officer, Robert Stefanovich, sold 1,079 shares of common stock on March 25, 2024, to cover tax obligations related to vesting restricted stock rights.
NASDAQ
Cryoport's CEO, Jerrell Shelton, sold 2,631 shares of common stock on March 25, 2024, to cover tax obligations related to vesting restricted stock rights.
NASDAQ
Cryoport's Chief Scientific Officer, Mark Sawicki, sold 1,367 shares of common stock on March 25, 2024, to cover tax obligations related to vesting restricted stock rights.
NASDAQ
Edward Zecchini, Chief Digital and Tech Officer of Cryoport, reports acquiring 10,455 shares of common stock and disposing of 63,494 shares.
NASDAQ
Robert Stefanovich, CFO of Cryoport, Inc., reports the conversion of restricted stock rights, sale of common stock for tax obligations, and acquisition of new restricted stock rights and stock options.
NASDAQ
Mark Sawicki, Chief Scientific Officer of Cryoport, Inc., reports the conversion of restricted stock rights, sale of common stock for tax obligations, and acquisition of new restricted stock rights and stock options.
NASDAQ
Director Ramkumar Mandalam exercised stock options and sold a portion of the acquired shares of Cryoport, Inc.
NASDAQ
Director Linda Baddour converted restricted stock rights into common stock of Cryoport, Inc. on March 15, 2024.
NASDAQ
Cryoport's CEO, Jerrell Shelton, reports multiple transactions involving common stock and derivative securities, including acquisitions, disposals, and conversions of restricted stock rights and stock options.